<DOC>
	<DOCNO>NCT02381249</DOCNO>
	<brief_summary>Improvements treatment strategy patient cancer upper gastrointestinal tract produce large population people remain free cancer recurrence long term follow treatment . Surgery cornerstone treatment patient cancer , surgical removal tumour may offer best chance cure , major operation associate specific long term complication . Weight loss poor nutrition common problem among patient attain long-term cancer remission cure surgery . The mechanisms underlying problem well understood therefore treatment option limit . Our research demonstrate increased level chemical messenger ( gut hormone ) release gastrointestinal tract meal patient previously undergone type surgery . These chemical messenger play role control appetite interest food , increase level surgery may reduce interest eating . Understanding role gut hormone control appetite may allow u use certain medication block gut hormone hence increase appetite , allow patient eat regain weight , prevent nutritional problem surgery . In study , investigator aim determine whether exaggerated gut hormone secretion cause reduced appetite interest food surgery . The information gain study may help u develop treatment patient weight loss nutritional problem surgery .</brief_summary>
	<brief_title>The Effect Satiety Gut Hormone Modulation Appetitive Drive After Upper Gastrointestinal Surgery</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Weight Loss</mesh_term>
	<mesh_term>Malnutrition</mesh_term>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Duodenal Neoplasms</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Octreotide</mesh_term>
	<criteria>Inclusion criterion : 1 . Surgical procedure : Twostage , threestage transhiatal esophagectomy gastric conduit reconstruction pyloroplasty , total gastrectomy RouxenY reconstruction , pancreaticoduodenectomy , match healthy unoperated control subject 2 . Diseasefree least one year postresection Exclusion criterion : 1 . Pregnancy , breastfeed 2 . Significant persistent chemoradiotherapy and/or surgical complication 3 . Other previous upper gastrointestinal surgery 4 . Unwell unable eat 5 . Other disease medication may affect satiety gut hormone responses 6 . Active significant psychiatric illness include substance misuse 7 . Cognitive communication issue factor affect capacity consent participation 8 . History significant food allergy , certain dietary restriction 9 . Confirmed suspected residual recurrent disease surgery , second primary malignancy 10 . Requiring adjuvant chemotherapy 11 . Contraindication octreotide administration 12 . History eat disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Esophagectomy</keyword>
	<keyword>Gastrectomy</keyword>
	<keyword>Octreotide</keyword>
	<keyword>Somatostatin</keyword>
	<keyword>Appetite</keyword>
	<keyword>Hunger</keyword>
	<keyword>Glucagon-Like Peptide 1</keyword>
	<keyword>Peptide YY</keyword>
	<keyword>Reinforcement</keyword>
	<keyword>Reward</keyword>
	<keyword>Psychological Phenomena Processes</keyword>
	<keyword>Gastrointestinal Agents</keyword>
	<keyword>Nutritional Status</keyword>
	<keyword>Pancreaticoduodenectomy</keyword>
	<keyword>Whipple Procedure</keyword>
</DOC>